Low-Dose Aspirin: Clinical Trials

23 trials of Low-Dose Aspirin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed, 6 recruiting, 3 not yet recruiting, 3 unknown. 6 Not applicable, 5 Phase 3, 5 Phase 4, 3 Phase 2, 2 Early Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable6Completed 4, Active not recruiting 1, Not yet recruiting 1
Phase 35Completed 2, Recruiting 2, Not yet recruiting 1
Phase 45Recruiting 2, Not yet recruiting 1, Unknown 1, Withdrawn 1
Phase 23Completed 1, Recruiting 1, Unknown 1
Early Phase 12Recruiting 1, Terminated 1

Follow Low-Dose Aspirin: new trials by email Literature Review of Low-Dose Aspirin trials Research Report on Low-Dose Aspirin

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Low Dose Aspirin to Lower Inflammation and Prevent Endometrial Cancer in Postmenopausal Women With Non-atrophic Endometrial Changes and Pain
Biospecimen Collection, Low-Dose Aspirin, Patient Observation - Endometrial Carcinoma
Phase 4Not yet recruitingMayo Clinic202027-02-122026-08-05
Low Dose Aspirin vs Placebo in Prevention of Recurrent Spontaneous Preterm Labour
Low-dose Aspirin, Placebo - Preterm Labor, Premature Birth
Not applicableNot yet recruitingUniversity of Health Sciences Lahore1622026-08-202026-08-12
Can Aspirin Reduce the Risk of HCC in Cirrhosis: The AspiRe HCC Trial
Low-dose aspirin, Placebo Comparator - Liver Cirrhosis
Phase 3Not yet recruitingCurtin University8902026-06-012026-04-14
Comparison of Pregnancy Outcomes in Primigravida Receiving Low-Dose Aspirin for the Prevention of Preeclampsia.
Low-dose aspirin, No-Aspirin - Preeclampsia
Not applicableCompletedMuhammad Aamir Latif1602025-08-012026-10-01
One-Month DAPT in CABG Patients
Ticagrelor 90 MG, Low-dose aspirin - Chronic Coronary Disease
Phase 3RecruitingWeill Medical College of Cornell University7002024-08-152025-12-22
Treatment With Aspirin After Preeclampsia: TAP Trial
Low-dose aspirin, Placebo - Hypertensive Disorder of Pregnancy, Pre-Eclampsia
Phase 4RecruitingMalamo Countouris602024-05-292026-09-22
A Study to Evaluate P1101 in Japanese PV Patients
P1101, Low-dose aspirin, Phlebotomy - Polycythemia Vera (PV)
Phase 3CompletedPharmaEssentia Japan K.K.212023-10-172024-11-08
Aspirin Dose Comparison in Elderly PCI Patients: 30mg vs. 75mg in Acute Coronary Syndrome
Low-dose aspirin - Myocardial Infarction, Acute Coronary Syndrome
Phase 2UnknownMedical University of Warsaw402023-07-032024-02-12
Non-surgical Periodontitis Treatment With Aspirin and Omega-3
Scaling and Root Planing (SRP), Omega-3 Fatty Acids, Low-dose aspirin - Periodontitis, Periodontitis (Stage 3)
Not applicableActive not recruitingHanoi Medical University1202023-04-012026-04-15
Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer
Biospecimen Collection, Low-Dose Aspirin, Questionnaire Administration - Breast Carcinoma
Phase 2RecruitingMayo Clinic602023-03-092026-10-01
LDA and LMWH vs LDA Alone in High-risk Patients for Preeclampsia Prevention
Aspirin, Tinzaparin - Preeclampsia Severe, Toxemia Of Pregnancy
Phase 4RecruitingAlexandra Hospital, Athens, Greece1002023-01-182026-01-23
AVAJAK: Apixaban/Rivaroxaban Versus Aspirin for Primary Prevention of Thrombo-embolic Complications in JAK2V617F-positive Myeloproliferative Neoplasms
Direct Oral Anticoagulants, Low-dose aspirin - Polycythemia Vera, Essential Thrombocythemia
Phase 3RecruitingUniversity Hospital, Brest13082022-07-132026-03-20
The Investigation of the Prediction Model and Prevention Strategy of Serious Pregnancy Complications in Hypertensive Disorders of Pregnancy Based on the Chinese Population
Low-dose aspirin - Hypertensive Disorder of Pregnancy, Pregnancy Complications
UnknownWomen's Hospital School Of Medicine Zhejiang University45002021-11-302021-12-02
Adherence to Universal Aspirin Compared to Screening Indicated Aspirin for Prevention of Preeclampsia
Low-dose aspirin - Medication Adherence, Preeclampsia
Phase 4WithdrawnWomen and Infants Hospital of Rhode Island2021-03-032025-04-04
Hydroxychloroquine in Prevention of Preeclampsia
Hydroxychloroquine, Folic acid, Low-dose aspirin - Preeclampsia
Not applicableCompletedAssiut University502021-03-012023-12-08
Identification of Critical Thermal Environments for Aged Adults
Low dose ASA, Control - Aging
Early Phase 1RecruitingPenn State University1902020-12-302026-01-27
Low-dose Aspirin Therapy in Patients With Ischemic Stroke and Microbleeds
low-dose aspirin, conventional-does aspirin - Ischemic Stroke
Phase 4UnknownXijing Hospital4002020-10-012022-02-09
Postpartum Low-Dose Aspirin After Preeclampsia for Optimization of Cardiovascular Risk (PAPVASC)
Low-dose aspirin, Placebo oral tablet - Preeclampsia Severe, Cardiovascular Diseases
Early Phase 1TerminatedDr. Graeme Smith142020-09-142024-04-05
Low Dose Aspirin for Preventing Intrauterine Growth Restriction and Preeclampsia in Sickle Cell Pregnancy (PIPSICKLE)
Low-dose aspirin, Placebo - Intrauterine Growth Restriction, Preeclampsia
Phase 3CompletedUniversity of Lagos, Nigeria4762020-07-012025-01-09
Hydroxychloroquine and Unexplained Recurrent Miscarriage
Hydroxychloroquine, Folic Acid, Low-dose aspirin - Unexplained Recurrent Miscarriage
Not applicableCompletedAssiut University1562020-01-012023-12-07

Showing 20 of 23. Sign in to see all of them.

Conditions studied

Pre-Eclampsia (7)  ·  Pregnancy Complications (4)  ·  Cardiovascular Diseases (3)  ·  Polycythemia Vera (3)  ·  Toxemia (3)  ·  Hypertension, Pregnancy-Induced (2)  ·  Myeloproliferative Disorders (2)  ·  Acute Coronary Syndrome (1)  ·  Anemia, Sickle Cell (1)  ·  Breast Neoplasms (1)  ·  Carcinoma (1)  ·  Colorectal Neoplasms (1)  ·  Eclampsia (1)  ·  Endometrial Neoplasms (1)  ·  Fetal Growth Retardation (1)

Sponsors

Assiut University (2)  ·  Mayo Clinic (2)  ·  PharmaEssentia Japan K.K. (2)  ·  Alexandra Hospital, Athens, Greece (1)  ·  Bayer (1)  ·  Curtin University (1)  ·  Dr. Graeme Smith (1)  ·  Hanoi Medical University (1)  ·  Malamo Countouris (1)  ·  Medical University of Warsaw (1)  ·  Muhammad Aamir Latif (1)  ·  Penn State University (1)  ·  University Hospital, Brest (1)  ·  University of Health Sciences Lahore (1)  ·  University of Lagos, Nigeria (1)

Countries

United States (6)  ·  China (3)  ·  Canada (2)  ·  Egypt (2)  ·  Japan (2)  ·  Austria (1)  ·  Finland (1)  ·  France (1)  ·  Germany (1)  ·  Greece (1)  ·  Italy (1)  ·  Nigeria (1)  ·  Pakistan (1)  ·  Poland (1)  ·  Sweden (1)

Top investigators

Alisse K Hauspurg, MD (1)  ·  Baohua Li, Phd (1)  ·  Bosede B Afolabi, DM (Nott) (1)  ·  Christopher C. DeStephano, MD, MPH (1)  ·  Georgios Daskalakis, PhD (1)  ·  Graeme N Smith, MD, PhD (1)  ·  Hannu Martikainen, MD (1)  ·  Helena Tinkanen, MD (1)  ·  John K Olynyk, BMedSc MBBS FRACP MD FAASLD (1)  ·  Juha Rasanen, MD (1)  ·  Juha S Tapanainen, Prof (1)  ·  Kathryn J. Ruddy, MD (1)  ·  Marc Ruel, MD, MPH (1)  ·  Mario Gaudino, MD, PhD, MSCE (1)  ·  Mariusz Tomaniak, PhD (1)

Results publications

PMID 19153091, PMID 20943705, PMID 24711050, PMID 26551178, PMID 29217662, PMID 29562586, PMID 29748422, PMID 30056389, PMID 30870274, PMID 32114852, PMID 38436365, PMID 40313042, PMID 41713441

NIH funding

2023 (1), K23HL168356 (1), R01CA262393 (1)